In a recent study, the researchers discovered that galectin-9 levels and Tim-3 was markedly elevated in CLL patients and the percentage of Tim-3 on T cells and galectin-9 levels increased as the disease progressed [12]. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.